These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32852290)

  • 41. Targeted next generation sequencing (NGS) to classify melanocytic neoplasms.
    Zarabi SK; Azzato EM; Tu ZJ; Ni Y; Billings SD; Arbesman J; Funchain P; Gastman B; Farkas DH; Ko JS
    J Cutan Pathol; 2020 Aug; 47(8):691-704. PubMed ID: 32291779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.
    McNeal AS; Liu K; Nakhate V; Natale CA; Duperret EK; Capell BC; Dentchev T; Berger SL; Herlyn M; Seykora JT; Ridky TW
    Cancer Discov; 2015 Oct; 5(10):1072-85. PubMed ID: 26183406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. On the nature of histologic observations: the case of the Spitz nevus.
    Piepkorn M
    J Am Acad Dermatol; 1995 Feb; 32(2 Pt 1):248-54. PubMed ID: 7829711
    [No Abstract]   [Full Text] [Related]  

  • 44. From melanocytes to melanomas.
    Shain AH; Bastian BC
    Nat Rev Cancer; 2016 Jun; 16(6):345-58. PubMed ID: 27125352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
    Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D
    Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723
    [No Abstract]   [Full Text] [Related]  

  • 46. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
    Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
    Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma.
    Siroy AE; Aung PP; Torres-Cabala CA; Tetzlaff MT; Nagarajan P; Milton DR; Curry JL; Ivan D; Prieto VG
    Hum Pathol; 2017 Jan; 59():48-54. PubMed ID: 27666765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular pathogenesis of cutaneous melanocytic neoplasms.
    Ibrahim N; Haluska FG
    Annu Rev Pathol; 2009; 4():551-79. PubMed ID: 19400696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Nevus associated malignant melanomas--diagnostic validation and prognosis].
    Stadler R; Garbe C
    Hautarzt; 1991 Jul; 42(7):424-9. PubMed ID: 1938395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions.
    Minca EC; Al-Rohil RN; Wang M; Harms PW; Ko JS; Collie AM; Kovalyshyn I; Prieto VG; Tetzlaff MT; Billings SD; Andea AA
    Mod Pathol; 2016 Aug; 29(8):832-43. PubMed ID: 27174586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expanding spectrum of "spitzoid" lesions: a small series of 4 cases with MAP2K1 mutations.
    Kerckhoffs KGP; Aallali T; Ambarus CA; Sigurdsson V; Jansen AML; Blokx WAM
    Virchows Arch; 2021 Jul; 479(1):195-202. PubMed ID: 33040161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trajectories of premalignancy during the journey from melanocyte to melanoma.
    Colebatch AJ; Scolyer RA
    Pathology; 2018 Jan; 50(1):16-23. PubMed ID: 29132722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Differential diagnosis and management of melanocytic lesions of the ocular surface].
    Tóth G; Szalai E; Csákány B; Hécz R; Sándor GL; Lukáts O; Nagy ZZ; Szentmáry N
    Orv Hetil; 2020 Apr; 161(15):563-574. PubMed ID: 32320191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sebocyte-like cell primary cutaneous melanoma: a rare cytologic variant of malignant melanoma.
    Molina-Ruiz AM; Ortiz-Reina S; Carranza C; Kutzner H; Requena L
    Am J Dermatopathol; 2015 Nov; 37(11):862-5. PubMed ID: 25830719
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How, and from which cell sources, do nevi really develop?
    Grichnik JM; Ross AL; Schneider SL; Sanchez MI; Eller MS; Hatzistergos KE
    Exp Dermatol; 2014 May; 23(5):310-3. PubMed ID: 24588745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling.
    Latchana N; Del Campo SE; Grignol VP; Clark JR; Albert SP; Zhang J; Wei L; Aldrink JH; Nicol KK; Ranalli MA; Peters SB; Gru A; Trihka P; Payne PR; Howard JH; Carson WE
    Ann Surg Oncol; 2017 Feb; 24(2):347-354. PubMed ID: 27469124
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Classification of cutaneous malignant melanoma: a reassessment of histopathologic criteria for the distinction of different types.
    Weyers W; Euler M; Diaz-Cascajo C; Schill WB; Bonczkowitz M
    Cancer; 1999 Jul; 86(2):288-99. PubMed ID: 10421265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Melanoma progression.
    Elder DE
    Pathology; 2016 Feb; 48(2):147-54. PubMed ID: 27020387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Videomicroscopy in differential diagnosis of skin tumors and secondary prevention of malignant melanoma].
    Dummer W; Doehnel KA; Remy W
    Hautarzt; 1993 Dec; 44(12):772-6. PubMed ID: 8113040
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Massively parallel sequencing analysis of benign melanocytic naevi.
    Lozada JR; Geyer FC; Selenica P; Brown D; Alemar B; Merghoub T; Berger MF; Busam KJ; Halpern AC; Weigelt B; Reis-Filho JS; Hollmann TJ
    Histopathology; 2019 Jul; 75(1):29-38. PubMed ID: 30791119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.